UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000040986
Receipt No. R000046765
Scientific Title Effectiveness of personal health records in medical treatment support for patients with chronic diseases
Date of disclosure of the study information 2020/07/15
Last modified on 2020/07/02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effectiveness of personal health records in medical treatment support for patients with chronic diseases
Acronym Effectiveness of personal health records
Scientific Title Effectiveness of personal health records in medical treatment support for patients with chronic diseases
Scientific Title:Acronym Effectiveness of personal health records in medical treatment support for patients with chronic diseases
Region
Japan

Condition
Condition diabetes and chronic liver disease
Classification by specialty
Hepato-biliary-pancreatic medicine Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 1) Evalustion of the effect of PHR and FGM on the physiological data and patient-reported outcome of diabetes patients
2) Evaluation of the effect of PHR on the parthenogenesis of NASH patients
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Glycemic control of the patients with diabetes and body weight reduction of those with NASH
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Behavior,custom
Interventions/Control_1 1. Inclusion - 3 month: patient uses PHR App and receives general medical care
2. 4-6 month: 1 and medical care by nurses using PHR data
3. 7-9 month: 1, 2 and medical care by nurses using message function of PHR
4. 10-18 month: general medical care. Use of PHR is up to the patients.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
35 years-old <=
Age-upper limit
75 years-old >
Gender Male and Female
Key inclusion criteria 1. Patients with diabetes and/or NASH who are older than 20 y.o.
2. Diabetes patients who are treated with self-injection (insulin and GLP-1 agonist) and monitored their glucose level using FGM.
3. NASH patients are diagnosed by liver biopsy or imaging exam before inclusion.
Key exclusion criteria 1. Patients who cannot use PHR due to lack of understanding, visual impairment, cognitive impairment and movement disorder of the fingers.
2. Patients who are considered to be impropriety for the participation in this study by physician.
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Keizo
Middle name
Last name Anzai
Organization Faculty of Medicine, Saga University
Division name Metabolism and Endocrinology
Zip code 849-8501
Address 5-1-1 Nabeshima,Saga
TEL 0952-31-6511
Email akeizo@cc.saga-u.ac.jp

Public contact
Name of contact person
1st name Hirokazu
Middle name
Last name Takahashi
Organization Faculty of Medicine, Saga University
Division name Metabolism and Endocrinology
Zip code 849-8501
Address 5-1-1 Nabeshima,Saga
TEL 0952-31-6511
Homepage URL
Email takahas2@cc.saga-u.ac.jp

Sponsor
Institute Saga University
Institute
Department

Funding Source
Organization Budget is covered by non-particular research funding of Division of Metabolism and Endocrinology, Saga University.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Clinical Research Center, Saga University Hospital
Address 5-1-1 Nabeshima,Saga
Tel 0952-34-3400
Email clinstudycenter@mail.admin.saga-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 07 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 12 Month 26 Day
Date of IRB
2020 Year 03 Month 02 Day
Anticipated trial start date
2020 Year 07 Month 15 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 07 Month 02 Day
Last modified on
2020 Year 07 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046765

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.